Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks

View ORCID ProfileLouisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius Schmidt, Sascha David, View ORCID ProfileHans-Martin Jäck, Edith Roth, View ORCID ProfileMarkus Cornberg, Thomas F. Schulz, View ORCID ProfileTobias Welte, View ORCID ProfileMarius M. Höper, View ORCID ProfileChristine S. Falk
doi: https://doi.org/10.1101/2021.07.08.21260169
Louisa Ruhl
1Institute of Transplant Immunology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louisa Ruhl
Isabell Pink
2Department of Pneumology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny F. Kühne
1Institute of Transplant Immunology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Beushausen
1Institute of Transplant Immunology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Keil
1Institute of Transplant Immunology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stella Christoph
1Institute of Transplant Immunology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Sauer
2Department of Pneumology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennart Boblitz
2Department of Pneumology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julius Schmidt
2Department of Pneumology, MHH, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sascha David
3Department of Intensive Care Medicine, University of Zurich, CH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Martin Jäck
4Division of Molecular Immunology, Internal Medicine III, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hans-Martin Jäck
Edith Roth
4Division of Molecular Immunology, Internal Medicine III, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Cornberg
5Department of Gastroenterology Hepatology and Endocrinology, MHH, D
6Center for Individualized Infection Medicine CiiM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Markus Cornberg
Thomas F. Schulz
7Institute of Virology, MHH, D
9German Center for Infection Research, DZIF, TTU-IICH
10Excellence Cluster 2155 RESIST, MHH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Welte
2Department of Pneumology, MHH, D
8German Center for Lung Diseases DZL/BREATH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tobias Welte
Marius M. Höper
2Department of Pneumology, MHH, D
8German Center for Lung Diseases DZL/BREATH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marius M. Höper
Christine S. Falk
1Institute of Transplant Immunology, MHH, D
8German Center for Lung Diseases DZL/BREATH
9German Center for Infection Research, DZIF, TTU-IICH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christine S. Falk
  • For correspondence: falk.christine@mh-hannover.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The systemic processes involved in the manifestation of life-threatening COVID-19 and in disease recovery are still incompletely understood, despite investigations focusing on the dysregulation of immune responses after SARS-CoV-2 infection. To define hallmarks of severe COVID-19 and disease recovery in convalescent patients, we combined analyses of immune cells and cytokine/chemokine networks with endothelial activation and injury. ICU patients displayed an altered immune signature with prolonged lymphopenia but expansion of granulocytes and plasmablasts along with activated and terminally differentiated T and NK cells and high levels of SARS-CoV-2-specific antibodies. Core signature of seven plasma proteins revealed a highly inflammatory microenvironment in addition to endothelial injury in severe COVID-19. Changes within this signature were associated with either disease progression or recovery. In summary, our data suggest that besides a strong inflammatory response, severe COVID-19 is driven by endothelial activation and barrier disruption, whereby recovery depends on the regeneration of the endothelial integrity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was supported by the German Research Foundation DFG FA-483/1-1, the German Center for Infection Research DZIF TTU-IICH 07_913 and the Lower Saxony Ministry of Research and Culture (ImProVIT). HMJ is supported by a grant (01KI2043) from the Bundesmininisterium fuer Bildung und Forschung (BMBF), funds from the Bavarian State ministry for Science and the BMBF-funded COVIM project (NaFoUniMedCovid19).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Hannover Medical School Ethics Committee. All patients or participants provided written informed consent before participation in the study (9001 BO K, 968-2011).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of interest statement The authors have declared that no conflict of interest exists.

Data Availability

All data associated with this study are available in the main text or the supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Louisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius Schmidt, Sascha David, Hans-Martin Jäck, Edith Roth, Markus Cornberg, Thomas F. Schulz, Tobias Welte, Marius M. Höper, Christine S. Falk
medRxiv 2021.07.08.21260169; doi: https://doi.org/10.1101/2021.07.08.21260169
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Louisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius Schmidt, Sascha David, Hans-Martin Jäck, Edith Roth, Markus Cornberg, Thomas F. Schulz, Tobias Welte, Marius M. Höper, Christine S. Falk
medRxiv 2021.07.08.21260169; doi: https://doi.org/10.1101/2021.07.08.21260169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (735)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)